Therapeutic Targeting Potential of Novel Silver Nanoparticles Coated with Anti-CD20 Antibody against Chronic Lymphocytic Leukemia

Therapeutic Targeting Potential of Novel Silver Nanoparticles Coated with Anti-CD20 Antibody against Chronic Lymphocytic Leukemia

Background: Chronic lymphocytic leukemia (CLL) is an incurable disorder associated with alterations in several pathways essential for survival and proliferation. Despite the advances made in CLL therapy with the new target agents, in some cases, relapses and resistance could occur, making the discov...

Full description

Bibliographic Details
Main Authors: Francesco Maria Adamo, Estevao Carlos Silva Barcelos, Filomena De Falco, Erica Dorillo, Chiara Rompietti, Daniele Sorcini, Arianna Stella, Beatrice Del Papa, Stefano Baldoni, Angela Esposito, Clelia Geraci, Roberta Arcaleni, Chiara Pennetta, Francesco Ragonese, Lorenzo Moretti, Mariagrazia Mameli, Mauro Di Ianni, Emanuela Rosati, Bernard Fioretti, Paolo Sportoletti
Format: Article
Language:English
Published: MDPI AG 2023-07-01
Series:Cancers
Subjects:
chronic lymphocytic leukemia
drug mechanisms
preclinical models
Online Access:https://www.mdpi.com/2072-6694/15/14/3618

Internet

https://www.mdpi.com/2072-6694/15/14/3618

Similar Items